Led US market launch efforts for a rare disease therapeutic

A mid-sized publicly traded specialty pharmaceutical company needed business and marketing expertise to prepare for the launch of a recently-acquired drug for a rare disease. TCG, with deep experience in the marketing of drugs for rare diseases, led the commercial efforts for the product within the company, developing and directing the drug’s overall strategy as well as launch plans. The product is awaiting approvals in both the US and Europe.